Menopausal Hormone Therapy

Menopausal Hormone Therapy May Provide These Health Benefits
Understanding the Treatment.
About Menopausal Hormone Therapy
Menopausal hormone therapy (MHT) replaces the estrogen and, when the uterus is intact, progesterone that decline at menopause, easing symptoms such as hot flashes, night sweats, sleep disruption, and mood changes. It can also help with vaginal dryness, urinary symptoms, and bone-loss prevention. Revibe’s providers customize your program based on your individual needs.
MHT is the most effective treatment for hot flashes and night sweats and also helps with sleep, mood, vaginal dryness and discomfort with sex, urinary symptoms, and prevention of bone loss. The degree of relief varies by person.
If you still have a uterus, a progestogen is generally included to protect the uterine lining from the effects of estrogen. If you’ve had a hysterectomy, estrogen alone is usually appropriate. Your Revibe Health provider confirms the right regimen.
Hormones can be delivered as pills, patches, gels, sprays, and vaginal preparations, dosed continuously or cyclically. Your Revibe provider selects the combination and delivery system that best match your symptoms, preferences, and risk factors.
There’s no single fixed duration; the right length depends on your symptoms, goals, and ongoing benefit-risk assessment, which your provider revisits over time.
For localized genitourinary symptoms, low-dose vaginal estrogen is a targeted option with minimal systemic absorption, and it can often be used when systemic therapy isn’t needed or preferred. Your provider will match the approach to your symptoms.
Safety and Side Effects
For many healthy women with bothersome symptoms, benefits outweigh risks particularly when started before age 60 or within about 10 years of menopause. Safety depends on your age, health history, and the hormones and routes used, so your Revibe care is individualized and monitored.
Depending on the regimen, MHT can carry risks such as blood clots or stroke, and certain combination therapies used over time have been linked to a small increase in breast cancer risk. Common short-term side effects include breast tenderness, bloating, and irregular bleeding. Your Revibe provider weighs these against your symptoms.
It’s generally avoided in women with a history of breast or estrogen-sensitive cancers, unexplained vaginal bleeding, active liver disease, or a history of blood clots or stroke. Your Revibe Health provider reviews your history to determine whether it would be recommended for your program.







